33
Views
12
CrossRef citations to date
0
Altmetric
Review

Ligands of the melanocortin receptors, 2002 – 2003 update

&
Pages 327-336 | Published online: 02 Mar 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dai Nozawa, Shigeyuki Chaki & Atsuro Nakazato. (2008) Recent advances in the development of melanocortin-4 receptor ligands. Expert Opinion on Therapeutic Patents 18:4, pages 403-427.
Read now

Articles from other publishers (11)

Kenneth A. Gruber, Ren-Lai Ji, Fabio Gallazzi, Shaokai Jiang, Steven R. Van Doren, Ya-Xiong Tao & Jessica Newton Northup. (2022) Development of a Therapeutic Peptide for Cachexia Suggests a Platform Approach for Drug-like Peptides. ACS Pharmacology & Translational Science 5:5, pages 344-361.
Crossref
Margit Pissarek & Ulrich Disko. (2013) Non-peptide ligands in the characterization of peptide receptors at the interface between neuroendocrine and mental diseases. World Journal of Neuroscience 03:02, pages 100-125.
Crossref
Jerzy R. Szewczyk, Chris P. Laudeman, Doug M. Sammond, Manon Villeneuve, Douglas J. Minick, Mary K. Grizzle, Alejandro J. Daniels, John L. Andrews & Diane M. Ignar. (2010) A concise synthesis of 1,4-dihydro-[1,4]diazepine-5,7-dione, a novel 7-TM receptor ligand core structure with melanocortin receptor agonist activity. Bioorganic & Medicinal Chemistry 18:5, pages 1822-1833.
Crossref
Thomas R. Webb, Luyong Jiang, Sergey Sviridov, Ruben E. Venegas, Anna V. Vlaskina, Douglas McGrath, John Tucker, Jian Wang, Alain Deschenes & Rongshi Li. (2007) Application of a Novel Design Paradigm to Generate General Nonpeptide Combinatorial Templates Mimicking β-Turns:  Synthesis of Ligands for Melanocortin Receptors. Journal of Combinatorial Chemistry 9:4, pages 704-710.
Crossref
Sergei Kopanchuk, Santa Veiksina, Felikss Mutulis, Ilze Mutule, Sviatlana Yahorava, Ilona Mandrika, Ramona Petrovska, Ago Rinken & Jarl E.S. Wikberg. (2006) Kinetic evidence for tandemly arranged ligand binding sites in melanocortin 4 receptor complexes. Neurochemistry International 49:5, pages 533-542.
Crossref
James P. Cain, Alexander V. Mayorov, Minying Cai, Hui Wang, Bahar Tan, Kevin Chandler, YeonSun Lee, Ravil R. Petrov, Dev Trivedi & Victor J. Hruby. (2006) Design, synthesis, and biological evaluation of a new class of small molecule peptide mimetics targeting the melanocortin receptors. Bioorganic & Medicinal Chemistry Letters 16:20, pages 5462-5467.
Crossref
Ravi P. Nargund, Alison M. Strack & Tung M. Fong. (2006) Melanocortin-4 Receptor (MC4R) Agonists for the Treatment of Obesity. Journal of Medicinal Chemistry 49:14, pages 4035-4043.
Crossref
Raman K. Bakshi, Qingmei Hong, Rui Tang, Rubana N. Kalyani, Tanya MacNeil, David H. Weinberg, Lex H.T. Van der Ploeg, Arthur A. Patchett & Ravi P. Nargund. (2006) Optimization of a privileged structure leading to potent and selective human melanocortin subtype-4 receptor ligands. Bioorganic & Medicinal Chemistry Letters 16:5, pages 1130-1133.
Crossref
Raman K. Bakshi, Qingmei Hong, J.T. Olson, Zhixiong Ye, Iyassue K. Sebhat, David H. Weinberg, Tanya MacNeil, Rubana N. Kalyani, Rui Tang, William J. Martin, Alison Strack, Erin McGowan, Constantin Tamvakopoulos, Randy R. Miller, Ralph A. Stearns, Wei Tang, D. Euan Maclntyre, Lex H.T. van der Ploeg, Arthur A. Patchett & Ravi P. Nargund. (2005) 1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: Application in the synthesis of potent human melanocortin-4 receptor selective agonists. Bioorganic & Medicinal Chemistry Letters 15:14, pages 3430-3433.
Crossref
Brenda L. Palucki, Min K. Park, Ravi P. Nargund, Rui Tang, Tanya MacNeil, David H. Weinberg, Aurawan Vongs, Charles I. Rosenblum, George A. Doss, Randall R. Miller, Ralph A. Stearns, Qianping Peng, Constantin Tamvakopoulos, Lex H.T. Van der Ploeg & Arthur A. Patchett. (2005) 2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonists. Bioorganic & Medicinal Chemistry Letters 15:8, pages 1993-1996.
Crossref
Brenda L. Palucki, Min K. Park, Ravi P. Nargund, Zhixiong Ye, Iyassu K. Sebhat, Patrick G. Pollard, Rubana N. Kalyani, Rui Tang, Tanya MacNeil, David H. Weinberg, Aurawan Vongs, Charles I. Rosenblum, George A. Doss, Randall R. Miller, Ralph A. Stearns, Qianping Peng, Constantin Tamvakopoulos, Erin McGowan, William J. Martin, Joseph M. Metzger, Cherrie A. Shepherd, Alison M. Strack, D. Euan MacIntyre, Lex H.T. Van der Ploeg & Arthur A. Patchett. (2005) Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonist. Bioorganic & Medicinal Chemistry Letters 15:1, pages 171-175.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.